A Global Phase III Clinical Trial of Recombinant COVID- 19 Vaccine (Sf9 Cells)

Name: A Global Phase III Clinical Trial of Recombinant COVID- 19 Vaccine (Sf9 Cells)
License: Public Domain

WestVac Biopharma Co., Ltd. · clinicaltrials

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

covid-19

ClinicalTrials.gov Show glossary Search for terms Hide glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.

Record · ID 28431 · SHA-256 17c3746fc8cd5ac2
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.